Impact of polypharmacy on clinical outcomes in patients with advanced heart failure undergoing cardiac resynchronization therapy
Hyperpolypharmacy was significantly associated with adverse cardiovascular outcomes in patients with advanced HFrEF who underwent CRT. Noncardiovascular polypharmacy may underlie the harmful effects of hyperpolypharmacy.
Authors
- Hiroki Sato (ORCID: https://orcid.org/0000-0002-6061-1511)
- Kazuki Mitarai
- Hidefumi Akioka
- Keisuke Yonezu
- Naohiko Takahashi (ORCID: https://orcid.org/0000-0001-9037-0010)
- Taisuke Harada (ORCID: https://orcid.org/0000-0002-2805-3003)
- Katsunori Tawara
- Kunio Yufu (ORCID: https://orcid.org/0000-0002-9668-7630)
- Hidekazu Kondo (ORCID: https://orcid.org/0000-0003-2451-5845)
- Yuma Ono
Institutions
- Oita University (JP)
Publication Details
- Journal
- Journal of Arrhythmia
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1002/joa3.13185
- Citations
- 2
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.80